Holding company stocks are getting a closer look as investors spend more time searching for value that is not always obvious on the surface.

The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies ...

National Priority Vouchers aim to shorten FDA review from ~10–12 months to ~1–2 months using collaborative multidisciplinary ...

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...

Dairy Queen's automated AI drive-thru initiative sparks customer concern as Meta lays off 8,000 workers and voters flag AI ...

After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use.

Nonprofits that use AI for more than routine tasks are seeing the payoff. Five leaders explain how to get started.

By Kamal Choudhury and Christy Santhosh April 24 (Reuters) - The U.S. health regulator on Friday moved to speed up the ...

The US has given three drugmakers accelerated pathways to approval for psychedelic medications with clinical trials underway.

HubSpot CPO Helen Russell says leaders must upskill for AI, think like founders, stay close to operations, and build trusted ...

Maybe the answer to spending too much time on the Internet isn't to abandon the digital world entirely, but to move through ...

The CIH Chairman and CEO explained why he’s pushing for more choice in how listings are marketed — and questioned the concept ...